Research participation for patients with spinal cord injury
As a patient with spinal cord injury, with C1, C2, and C7 fractures with contusion of the medulla oblongata until the C2 vertebra, I have always felt lonely in my search for the right clinical trials in which I could participate. I believe it is important to have the opportunity to discuss treatment options and patients' priorities on a regular basis with the treating neurologist or rehab ilitation physician. The possibility for research participation should be a normal part of these conversations. The pervasive culture that there will never be a cure for spinal cord injuries must change.
I was surprised to read the statement of Tom Shakespeare and Nicholas Watson 1 in The Lancet Neurology that making environments accessible or provid ing appropriate assistive technology would be more effective than trying to fix individuals with spinal cord injury. Assistive devices are a good option in the short term, but a spinal cord injury implies more problems than not being able to move. My assistive devices could not prevent my current need for haemodialysis.
There is no cure for spinal cord injuries at the moment, but there is con tinuous progress in research. Although not all patients will be openminded towards research partici pation, all patients should be well informed about the possibilities to participate in methodologically sound clinical trials and the potential benefits and harms of clinical trial partici pa tion. We can not change the future without research. Furthermore, making research parti ci pation discussable within standard consultations could pre vent patients from seeking unproven cell therapies abroad.
When I speak to my health-care providers about participation in trials of functional electrical stimulation, a proven therapy to improve cardiovascular health in patients with spinal cord injury, 3 I can perceive their skepticism in their eyes: why would you do this in your situation? But the only response I can think of is, why not? I would like to participate because I want to pre vent secondary complications from my spinal cord injury, I would like the feeling of movement, and I would like the idea of moving forward instead of resigning myself to my destiny. Furthermore, I want to be prepared for future therapies that might eventually restore part of the damage to my spinal cord.
In 2018, several papers reported on the effectiveness of epidural stimu lation in patients with spinal cord injury. [4] [5] [6] Although it is too early to integrate epidural stimulation into routine clinical practice, let's not make the mistake of leaving the ther apy unavailable for a large part of the target population. It would be unethical to first cheer about a possible breakthrough for patients with a spinal cord injury and not make it available to try afterwards. We know it is not a cure, but until there is a cure, there are are many people who would be happy with small improvements.
Not only is research participation imp ort ant, but also is the involvement of patients in determining research prior i ties. Benabid and colleagues 2 have dis cussed the clinical application of a four limb exoskeleton controlled by a brain-machine interface. I do not know if there are many tetraplegic patients looking forward to the use of brain implants to control exoskeletons, which could risk their intellect. Braincontrolled exoskeletons are not a real cure in daily life, but they are in the same category as other less risky assistive technologies. Within a context of scarce financial resources, setting the focus on neuroplasticity and regeneration might be a better option.
